Loading organizations...
Loading organizations...
Key people at Sarissa Capital.
Key people at Sarissa Capital.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 1, 2024 | Attralus | $56.0M Series B | Alpha Wave Ventures | 4BIO Capital, Abingworth, venBio, Bristol Myers Squibb, Logos Capital, Surveyor Capital, Vivo Capital |
| Dec 21, 2023 | Lyndra Therapeutics | $101.0M Series E | Sarissa Capital | Polaris Partners, Sun Pharmaceutical Industries |
| Sep 1, 2021 | Attralus | $120.0M Series B | Graham Walmsley | 4BIO Capital, Abingworth, venBio, Janus Henderson Investors, Redmile Group, Samsara BioCapital, Alex Denner, Surveyor Capital, Vivo Capital |
| Dec 1, 2020 | Pear Therapeutics | $80.0M Series D | Elena Viboch | f7 Ventures, General Catalyst, 5AM Ventures, Arboretum Ventures, CrimsoNox Capital, EDBI, Forth Management, JAZZ Venture Partners, Novartis, Pilot House Ventures, QUAD Investment Management, Shanda Group, Temasek |